As of Sep 30
| +0.02 / +0.08%|
The 6 analysts offering 12-month price forecasts for Healthways Inc have a median target of 26.50, with a high estimate of 29.00 and a low estimate of 22.50. The median estimate represents a +0.15% increase from the last price of 26.46.
The current consensus among 7 polled investment analysts is to Buy stock in Healthways Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.